Collegium Pharma (COLL) Reports Q1 Loss of $1.05/Share

Collegium Pharma (NASDAQ: COLL) reported Q1 EPS of ($1.05), versus ($0.45) reported last year.

For earnings history and earnings-related data on Collegium Pharma (COLL) click here.

You May Also Be Interested In

• Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
• LG Energy 2q Oper Profit 113.3b Won, Est. 210.66b Won - Bloomberg
• Morgan Stanley upgrades Ivanhoe Mines, cuts Alcoa and Vale on metals outlook